Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients

被引:83
作者
Knobler, H
Savion, N
Shenkman, B
Kotev-Emeth, S
Varon, D [1 ]
机构
[1] Chaim Sheba Med Ctr, Natl Hemophilia Ctr, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel
[3] Kaplan Hosp, Div Endocrinol, IL-76100 Rehovot, Israel
[4] Tel Aviv Univ, Goldschleger Eye Res Inst, Tel Hashomer, Israel
关键词
platelets aggregation; platelet adhesion; platelet activation; diabetes mellitus;
D O I
10.1016/S0049-3848(98)00050-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased platelet aggregation has been suggested to play a role in the accelerated atherosclerosis of diabetics, However the physiological relevance of the aggregation tests has been questioned. The purpose of this study was to determine platelet activation in diabetic patients, using a novel device-the cone and plate(let) analyzer-to measure shear-induced platelet adhesion and aggregation on extracellular matrix (ECM), Whole blood platelet adhesion and aggregation in patients with noninsulin-dependent diabetes mellitus (n = 82) and in nondiabetic controls (n = 71) were compared. Clinical and laboratory characteristics of the diabetic patients were analyzed for possible correlation with parameters of platelet activity. Patients with diabetes had a significantly increased platelet activation compared to nondiabetic subjects, demonstrated by an increased adhesion to the ECM (surface coverage, 23% [95% confidence interval, 22-25%] vs. 19% [95% confidence interval, 18-20%], respectively) and an increased average size of the ECM-bound aggregates (54 mu m(2) [95% confidence interval, 51-57 mu m(2)] vs. 47 mu m(2) [95% confidence inter val, 43-51 mu m(2)], respectively). Platelet adhesion in the diabetic group was found to correlate with triglyceride levels (r = 0.36) and hematocrit values (r = 0.31) and inversely with high-density lipoprotein cholesterol levels (r = 0.30). There were no correlation, however, between parameters of platelet reactivity and duration of diabetes, vascular complications and low-density lipoprotein levels. Our data demonstrate an increased platelet adhesion and aggregation in diabetic patients and suggest a modulatory role of diabetic dyslipidemia, (C) 1998 Elsevier Science Ltd.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 41 条
  • [1] THROMBOXANE BIOSYNTHESIS AND PLATELET-FUNCTION IN TYPE-I DIABETES-MELLITUS
    ALESSANDRINI, P
    MCRAE, J
    FEMAN, S
    FITZGERALD, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (04) : 208 - 212
  • [2] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [3] [Anonymous], 1988, LANCET, V2, P349
  • [4] Potential mechanisms promoting restenosis in diabetic patients
    Aronson, D
    Bloomgarden, Z
    Rayfield, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (03) : 528 - 535
  • [5] PLATELET LIPOPROTEIN INTERACTIONS
    BROOK, JG
    AVIRAM, M
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1988, 14 (03) : 258 - 265
  • [6] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY
    CALIFF, RM
    SHADOFF, N
    VALETT, N
    BATES, E
    GALEANA, A
    KNOPF, W
    SHAFTEL, J
    BENDER, MJ
    AVERSANO, T
    RAQUENO, J
    GURBEL, P
    COWFER, J
    COHEN, M
    CROSS, P
    BITTL, J
    EDDINGS, K
    TAYLOR, M
    DEROSA, K
    HATTEL, L
    COOPER, L
    ESHELMAN, B
    FINTEL, D
    NIEMYSKI, P
    KLEIN, L
    KENNEDY, H
    THORNTON, T
    KEREIAKES, D
    MARTIN, L
    ANDERSON, L
    HIGBY, N
    ELLIS, S
    BREZINA, K
    GEORGE, B
    CHAPEKIS, A
    SMITH, D
    ANWAR, A
    GERBER, TL
    PRITCHARD, GL
    MYLER, R
    SHAW, R
    MURPHY, M
    WARD, K
    MADIGAN, NP
    BLANKENSHIP, J
    HALBERT, M
    FLANAGAN, C
    TANNENBAUM, M
    POLICH, M
    STEVENSON, C
    TCHENG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) : 956 - 961
  • [7] RESTENOSIS AFTER ARTERIAL INJURY CAUSED BY CORONARY STENTING IN PATIENTS WITH DIABETES-MELLITUS
    CARROZZA, JP
    KUNTZ, RE
    FISHMAN, RF
    BAIM, DS
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (05) : 344 - 349
  • [8] COLLIER A, 1989, DIABETES METAB, V15, P420
  • [9] PLATELET-FUNCTION IN DIABETES-MELLITUS
    COLWELL, JA
    HALUSHKA, PV
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1980, 44 (04) : 521 - 526
  • [10] DO PLATELETS HAVE ANYTHING TO DO WITH DIABETIC MICROVASCULAR DISEASE
    COLWELL, JA
    WINOCOUR, PD
    HALUSHKA, PV
    [J]. DIABETES, 1983, 32 : 14 - 19